|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 66.37 USD | -1.38% |
|
-0.24% | -7.33% |
| May. 16 | Transcript : Intra-Cellular Therapies, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 09:20 AM | |
| May. 07 | Sector Update: Health Care Stocks Steady Pre-Bell Tuesday | MT |
Intra-Cellular Therapies, Inc. reiterated earnings guidance for the full year 2024. Full year 2024, the company reiterated CAPLYTA net product sales guidance of $645 to $675 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.33% | 7.11B | |
| -1.96% | 89.22B | |
| +1.32% | 40.49B | |
| -15.73% | 32.79B | |
| +64.13% | 26.23B | |
| -21.28% | 14.52B | |
| -8.50% | 13.09B | |
| -44.07% | 11.6B | |
| -13.06% | 11.5B | |
| +4.94% | 8.82B |
INTRA-CELLULAR THERAPIES, INC. 
